Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
CC transcript
Synaptogenix, Inc. (SNPX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/19/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Synaptogenix and Cleveland Clinic to Submit Investigational New Drug Application to FDA for Clinical Trial of Bryostatin-1 in Multiple Sclerosis"
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/28/2023 8-K Quarterly results
04/14/2023 8-K Quarterly results
03/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/21/2023 10-K Annual Report for the period ended December 31, 2022
03/20/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/07/2023 8-K Results of Operations and Financial Condition  Interactive Data
02/08/2023 SC 13G/A INTRACOASTAL CAPITAL, LLC reports a 10% stake in Synaptogenix, Inc.
01/18/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/09/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
12/28/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
12/28/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
12/28/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/16/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
12/16/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
11/22/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
11/22/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits ...
Docs: "CERTIFICATE OF DESIGNATIONS OF SERIES B CONVERTIBLE PREFERRED STOCK OF"
11/18/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "Form of Certificate of Designations",
"Form of Warrant",
"Form of Purchase Agreement",
"Form of Registration Rights Agreement",
"Engagement Letter, by and between Synaptogenix, Inc. and Katalyst Securities LLC",
"Press Release"
08/25/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/25/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/16/2022 8-K Quarterly results
08/05/2022 10-Q Quarterly Report for the period ended June 30, 2022
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/28/2022 EFFECT Form EFFECT - Notice of Effectiveness:
04/15/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/29/2022 10-K Annual Report for the period ended December 31, 2021
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2022 SC 13G/A HAYWOOD GEORGE WEAVER reports a 7% stake in Synaptogenix, Inc.
01/31/2022 SC 13G/A ALPHA CAPITAL ANSTALT reports a 4.5% stake in SYNAPTOGENIX, INC.
11/12/2021 10-Q Quarterly Report for the period ended September 30, 2021
10/01/2021 8-K Quarterly results
08/13/2021 10-Q Quarterly Report for the period ended June 30, 2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy